Waters Corporation (WAT) Enterprise Value (EV): $24.03B
The enterprise value (EV) for Waters Corporation (WAT) is $24.03B as of Thursday, June 11, 2026.
WAT Enterprise Value (EV) Metrics
ENTERPRISE VALUE (EV)
$24.03B
WAT Competitors' Enterprise Value (EV)
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Waters Corporation (WAT) | $23.21B | $24.03B |
| United Therapeutics Corporation (UTHR) | $23.15B | $20.03B |
| Mettler-Toledo International Inc. (MTD) | $23.06B | $31.01B |
| BioNTech SE (BNTX) | $22.39B | $14.31B |
| Veeva Systems Inc. (VEEV) | $26.31B | $32.05B |
| Moderna, Inc. (MRNA) | $19.70B | $10.79B |
| DexCom, Inc. (DXCM) | $29.04B | $26.37B |
| Hologic, Inc. (HOLX) | $16.97B | $15.94B |
| Biogen Inc. (BIIB) | $29.52B | $29.76B |
| IQVIA Holdings Inc. (IQV) | $30.22B | $52.94B |
Enterprise Value Calculation
Market Cap
$23.21B
Total Debt
$1.41B
Cash
$587.83M
Enterprise Value
$24.03B
EV-Based Valuation Multiples
Why use EV instead of Market Cap?
- EV accounts for debt - an acquirer must pay or assume it
- EV deducts cash - the acquirer effectively receives it
- EV enables fair comparison of companies with different capital structures
- EV-based ratios (EV/EBITDA, EV/Sales) are capital structure neutral
Waters Corporation Enterprise Value (EV) Formula & Definition
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Waters Corporation Enterprise Value (EV) FAQ
- What is the enterprise value (EV) for Waters Corporation (WAT)?
- The enterprise value (EV) for WAT stock is $24.03B.
Related Metrics
About Waters Corporation
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Udit Batra